Hope for Critically Ill Covid-19 Patients Within Reach 

There is new hope for severely ill patients with Covid-19. On March 30th, US company CytoDyn, released results from a randomized, double-blind study of a drug called leronlimab. The study revealed an unprecedented 82% reduction in the rate of death at Day 14 for patients on a ventilator who received 2 weekly doses of leronlimab More

Source: Hope for Critically Ill Covid-19 Patients Within Reach – CounterPunch.org

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s